Machine Learning Approaches in High Myopia: Systematic Review and Meta-Analysis (Preprint)

BACKGROUND In recent years, with the rapid development of machine learning (ML), it has gained widespread attention from researchers in clinical practice. ML models appear to demonstrate promising accuracy in the diagnosis of complex diseases, as well as in predicting disease progression and prognosis. Some studies have applied it to ophthalmology, primarily for the diagnosis of pathologic myopia and high myopia-associated glaucoma, as well as for predicting the progression of high myopia. ML-based detection still requires evidence-based validation to prove its accuracy and feasibility. OBJECTIVE This study aims to discern the performance of ML methods in detecting high myopia and pathologic myopia in clinical practice, thereby providing evidence-based support for the future development and refinement of intelligent diagnostic or predictive tools. METHODS PubMed, Cochrane, Embase, and Web of Science were thoroughly retrieved up to September 3, 2023. The prediction model risk of bias assessment tool was leveraged to appraise the risk of bias in the eligible studies. The meta-analysis was implemented using a bivariate mixed-effects model. In the validation set, subgroup analyses were conducted based on the ML target events (diagnosis and prediction of high myopia and diagnosis of pathological myopia and high myopia-associated glaucoma) and modeling methods. RESULTS This study ultimately included 45 studies, of which 32 were used for quantitative meta-analysis. The meta-analysis results unveiled that for the diagnosis of pathologic myopia, the summary receiver operating characteristic (SROC), sensitivity, and specificity of ML were 0.97 (95% CI 0.95-0.98), 0.91 (95% CI 0.89-0.92), and 0.95 (95% CI 0.94-0.97), respectively. Specifically, deep learning (DL) showed an SROC of 0.97 (95% CI 0.95-0.98), sensitivity of 0.92 (95% CI 0.90-0.93), and specificity of 0.96 (95% CI 0.95-0.97), while conventional ML (non-DL) showed an SROC of 0.86 (95% CI 0.75-0.92), sensitivity of 0.77 (95% CI 0.69-0.84), and specificity of 0.85 (95% CI 0.75-0.92). For the diagnosis and prediction of high myopia, the SROC, sensitivity, and specificity of ML were 0.98 (95% CI 0.96-0.99), 0.94 (95% CI 0.90-0.96), and 0.94 (95% CI 0.88-0.97), respectively. For the diagnosis of high myopia-associated glaucoma, the SROC, sensitivity, and specificity of ML were 0.96 (95% CI 0.94-0.97), 0.92 (95% CI 0.85-0.96), and 0.88 (95% CI 0.67-0.96), respectively. CONCLUSIONS ML demonstrated highly promising accuracy in diagnosing high myopia and pathologic myopia. Moreover, based on the limited evidence available, we also found that ML appeared to have favorable accuracy in predicting the risk of developing high myopia in the future. DL can be used as a potential method for intelligent image processing and intelligent recognition, and intelligent examination tools can be developed in subsequent research to provide help for areas where medical resources are scarce. CLINICALTRIAL PROSPERO CRD42023470820; https://tinyurl.com/2xexp738